JENKINS JOHN KENNETH sold 98.8% of their position (2.78K shares) of CORBUS PHARMACEUTICALS HOLDINGS, INC. on the open market
Open‑market sale worth $20.5K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/2/2025ACC: 0000950170-25-080311
Director
Since Mar 2019
+18.02K
Net shares
Net buyer
$20.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
20.80K acquired · 2.78K disposed
Non-Derivative Transactions2
Common Stock, par value $0.0001 per share
Direct
Shares
−2.78K
Price / share
$7.35
Trade value
$20.47K
% of position
98.8%
5/30/2025
2.82K→33.00
Common Stock, par value $0.0001 per share
Direct
Shares
+4.80K
Price / share
—
Trade value
—
% of position
14545.5%
5/30/2025
33.00→4.83K
Total
Net shares
+2.02K
Net value
-$20.47K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share Direct | 5/30/2025 | S · Sale | −2.78K | $7.35 | $20.47K | 98.8% | 2.82K | 33.00 |
| Common Stock, par value $0.0001 per share Direct | 5/30/2025 | A · Award | +4.80K | — | — | 14545.5% | 33.00 | 4.83K |
| Total | +2.02K | -$20.47K | ||||||
Derivative Transactions1
Stock options (right to buy)
Direct
Converts to
Common Stock
16K shares
Shares
+16K
Strike price
7.42
Held after
16K
Exercisable
—
5/30/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock options (right to buy) Direct | Common Stock16K shares | 5/30/2025 | A · Award | +16K | 7.42 | — | 16K |